21 Views | 27 Downloads
Correspondence: Jennifer S. Scherer, MD, 550 First Avenue, Bellevue CD Building, Room 665, New York, NY, 10016. Jennifer.scherer@nyulangone.org
Author contributions: Research idea and study design: JSS, BB, JS; KG, RPH, DC; data acquisition: BB, TM, BR, RPH, JSS; data analysis/interpretation: JSS, BB, RPH, JS, KG, JC, DC; statistical analysis: JSS, BB, RPH, JS, DC; supervision or mentorship: BB, RPH, JS, KG, JC, DC, TM, NAP. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved.
Competing interests: Dr Scherer reports a one-time honorarium from Vifor Pharmaceuticals, Cara Therapeutics, and is on the Clinical Advisory Board for Monogram Health. Dr Charytan reports personal fees from Merck, Boehringer, Eli Lilly, Gilead Astra Zeneca, Novo Nordisk, Gilead, and CSL Behring, as well as research support and grants from NovoNordisk, Amgen, and Medtronic. Natalia Alencar de Pinho declare financial support from pharmaceutical companies integrating the public-private partnership of the CKD-REIN cohort: Fresenius Medical Care, GlaxoSmithKline (GSK), Vifor France, and Boeringher Ingelheim. All grants are made to Paris Saclay University. Research grants from Fresenius Medical Care, National Council for Scientific and Technological Development, grants (paid to employer) from Astra Zeneca, Boehringer-Lilly, Novo Nordisk, Akebia, and Bayer for participation in advisory boards and educational activities. Roberto Pecoits-Filho is employed by Arbor Research Collaborative for health, that runs the DOPPS studies.
Global support for the ongoing DOPPS (Disease Outcomes and Practice Patterns Study) Programs is provided without restriction on publications by a variety of funders. Funding is provided to Arbor Research Collaborative for Health and not to Dr. Pecoits-Filho directly. Dr Scherer is supported by the NIDDK K23DK125840.
2023 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.